Professional Bladder Cancers and the Profession of Painter
NCT05937555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-07-10
Summary
This is a retrospective study on bladder cancer in French painters' population. The French agency ANSES collected data from all occupational and environmental diseases center in a specific database called RNV3P. We selected cases of bladder cancer in painters in four centers from 01/01/2010 to 31/12/2019. Those cases were analyzed in terms of occupational exposure, histology and sociodemographics data. Comparison between different histologic types of cancer, workplaces and occupational diseases process will be done.
Conditions
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-15
- Primary Completion
- 2022-01-28
- Completion
- 2022-01-28
Countries
- France
Study Locations
More Related Trials
-
Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
NCT02039310 ·Status: COMPLETED
-
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
NCT03558503 ·Status: COMPLETED ·Phase: PHASE2
-
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
NCT03013920 ·Status: COMPLETED
-
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT05243550 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy
NCT03307200 ·Status: COMPLETED
-
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998 ·Status: RECRUITING
-
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT03950362 ·Status: UNKNOWN ·Phase: PHASE2
-
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
NCT07251946 ·Status: COMPLETED
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
NCT02700724 ·Status: TERMINATED ·Phase: NA
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Basal Tumours in Bladder Cancer, Response to chemoTherapy
NCT04089748 ·Status: COMPLETED
-
Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
NCT06403202 ·Status: RECRUITING
-
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
NCT03788746 ·Status: COMPLETED
-
Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.
NCT04647981 ·Status: COMPLETED
-
FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors
NCT02149862 ·Status: COMPLETED ·Phase: NA
-
Prospective Bladder Cancer Infrastructure (ProBCI)
NCT04503577 ·Status: RECRUITING
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
NCT03673202 ·Status: UNKNOWN
-
Intravesical BCG: is the Urinary Bladder Ready to Receive it
NCT05335512 ·Status: NOT_YET_RECRUITING
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05508568 ·Status: UNKNOWN
-
Confocal Laser Endomicroscopy During TransUrethral Resection for Improving BC Diagnosis and Treatment
NCT05273593 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
NCT02276924 ·Status: COMPLETED ·Phase: NA